Published in J Clin Invest on July 01, 1977
Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1978) 3.08
Chemotactic peptide receptor modulation in polymorphonuclear leukocytes. J Cell Biol (1980) 2.72
Cell polarity: an examination of its behavioral expression and its consequences for polymorphonuclear leukocyte chemotaxis. J Cell Biol (1981) 2.64
Sensory adaptation of leukocytes to chemotactic peptides. J Cell Biol (1979) 2.61
Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci U S A (1984) 2.46
Modulating influence of chemotactic factor-induced cell adhesiveness on granulocyte function. J Clin Invest (1979) 2.30
Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest (1988) 2.30
Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A (1984) 2.28
Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro. J Clin Invest (1984) 2.27
Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states. J Clin Invest (1979) 2.01
Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes. Am J Pathol (1978) 1.91
Selective neutrophil desensitization to chemotactic factors. J Cell Biol (1979) 1.77
Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest (1986) 1.72
Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest (1986) 1.71
The cytokineplast: purified, stable, and functional motile machinery from human blood polymorphonuclear leukocytes. J Cell Biol (1982) 1.68
Systematic review of Purtscher's and Purtscher-like retinopathies. Eye (Lond) (2012) 1.67
1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. Am J Pathol (1981) 1.56
Role of complement activation in a model of adult respiratory distress syndrome. J Clin Invest (1980) 1.55
Degranulating stimuli decrease the neagative surface charge and increase the adhesiveness of human neutrophils. J Clin Invest (1980) 1.41
Association of the N-formyl-Met-Leu-Phe receptor in human neutrophils with a GTP-binding protein sensitive to pertussis toxin. Proc Natl Acad Sci U S A (1985) 1.39
Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Tex Heart Inst J (2013) 1.31
Rapid changes in light scattering from human polymorphonuclear leukocytes exposed to chemoattractants. Discrete responses correlated with chemotactic and secretory functions. J Clin Invest (1984) 1.30
A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus. J Clin Invest (1978) 1.28
Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages. J Exp Med (1982) 1.28
Virus infection of endothelial cells increases granulocyte adherence. J Clin Invest (1980) 1.27
Membrane activity and topography of F-Met-Leu-Phe-Treated polymorphonuclear leukocytes. Acute and sustained responses to chemotactic peptide. Am J Pathol (1982) 1.24
Granulocytes without degranulation: neutrophil function in granule-depleted cytoplasts. Proc Natl Acad Sci U S A (1983) 1.22
Substances which aggregate neutrophils. Mechanism of action. Am J Pathol (1978) 1.19
A clinicopathological case report of retinopathy of pancreatitis. Br J Ophthalmol (1982) 1.18
Chemotaxigenesis by cell surface components of Staphylococcus aureus. Infect Immun (1979) 1.17
Chemical synthesis of a gene encoding the human complement fragment C5a and its expression in Escherichia coli. Proc Natl Acad Sci U S A (1985) 1.17
Neutrophil aggregation and degranulation. Effect of arachidonic acid. Am J Pathol (1979) 1.15
Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest (1982) 1.13
Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis. J Exp Med (1994) 1.13
Phorbol myristate acetate: in vivo effects upon neutrophils, platelets, and lung. Am J Pathol (1980) 1.11
Enhancement of granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products. Proc Natl Acad Sci U S A (1982) 1.10
Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol (1991) 1.10
Ibuprofen in canine endotoxin shock. J Clin Invest (1982) 1.10
The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution. Ann Surg (1988) 1.05
The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure. J Exp Med (1994) 1.04
Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation. J Clin Invest (1988) 1.03
The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites. Biochem J (1987) 1.03
Lectinlike interactions of Fusobacterium nucleatum with human neutrophils. Infect Immun (1989) 1.03
Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysis. Clin Exp Immunol (1984) 1.01
Enhancement of hexose uptake in human polymorphonuclear leukocytes by activated complement component C5a. Proc Natl Acad Sci U S A (1979) 1.00
Complement-induced granulocyte aggregation in vivo. Am J Pathol (1981) 1.00
Human neutrophil aggregation and increased adherence to human endothelial cells induced by heat-aggregated IgG and immune complexes. Clin Exp Immunol (1981) 0.99
Reversal of hemodialysis granulocytopenia and pulmonary leukostasis: A clinical manifestation of selective down-regulation of granulocyte responses to C5adesarg. J Clin Invest (1981) 0.98
A novel assay for neutrophil clustering activity of human sera: relation to disease activity and neutropenia in systemic lupus erythematosus. Ann Rheum Dis (1990) 0.93
Evidence of complement catabolism in experimental acute pancreatitis. Am J Pathol (1980) 0.92
Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. J Exp Med (1990) 0.92
Enhancement of human neutrophil complement receptors: a comparison of the rosette technique with the uptake of radio-labelled anti-CR1 monoclonal antibody. Clin Exp Immunol (1985) 0.91
Aggregation of human polymorphonuclear leucocytes during phagocytosis of bacteria. Immunology (1984) 0.90
Alternative complement pathway activation increases mortality in a model of burn injury in mice. J Clin Invest (1982) 0.89
Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro. J Clin Invest (1981) 0.88
Acute generalized microvascular injury by activated complement and hypoxia: the basis of the adult respiratory distress syndrome and multiple organ failure? Br J Exp Pathol (1986) 0.86
Scanning electron microscopy of rheumatoid arthritis peripheral blood polymorphonuclear leucocytes. Ann Rheum Dis (1986) 0.85
Development of the adult respiratory distress syndrome: progressive alteration of neutrophil chemotactic and secretory processes. Am J Pathol (1984) 0.85
Platelet activating factor: an inhibitor of neutrophil activation? Clin Exp Immunol (1981) 0.85
The subcellular distribution of myeloid-related protein 8 (MRP8) and MRP14 in human neutrophils. J Transl Med (2005) 0.85
Circulating hydroxy fatty acids in familial Mediterranean fever. Proc Natl Acad Sci U S A (1985) 0.85
Chemotaxigenesis by encapsulated Staphylococcus aureus M. Infect Immun (1980) 0.84
Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2). Agents Actions (1981) 0.84
Enhancement of human polymorphonuclear leukocyte adherence to plastic and endothelium by phorbol myristate acetate. Comparison with human C5a. Am J Pathol (1986) 0.84
Lung injury induced by antibody fragments to angiotensin-converting enzyme. Am J Pathol (1981) 0.84
Synergy between phorbol esters, 1-oleyl-2-acetylglycerol, urushiol, and calcium ionophore in eliciting aggregation of marine sponge cells. Proc Natl Acad Sci U S A (1986) 0.84
Generation of chemotactic activity in serum by Haemophilus influenzae type b. Infect Immun (1984) 0.83
Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis. J Clin Invest (1979) 0.83
Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia. Immunology (1983) 0.82
Polymorphonuclear leucocytes in Crohn's disease and ulcerative proctocolitis: association between enhanced adherence to nylon fibre and disease variables. J Clin Pathol (1988) 0.82
Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis. Clin Exp Immunol (2002) 0.82
Role of arachidonic acid in stimulation of hexose transport by human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1980) 0.81
Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding. Protein Sci (1997) 0.81
Leukotriene B4 synthesis and metabolism by neutrophils and granule-free cytoplasts. Biochem J (1986) 0.81
The Chédiak-Higashi syndrome: ring-shaped lysomomes in circulating monocytes. Am J Pathol (1979) 0.80
Aggregation of rat neutrophils by nucleotide triphosphates. Br J Pharmacol (1982) 0.80
Immunological behaviour following rubella infection. Clin Exp Immunol (1979) 0.80
Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits. Infect Immun (1982) 0.80
Biological properties of human C5a: selected in vitro and in vivo studies. Clin Exp Immunol (1988) 0.80
Chemotactic factor-induced low density neutrophils express enhanced complement (CR1 and CR3) receptors and increased complement-dependent cytotoxicity. Clin Exp Immunol (1987) 0.80
Remission of psoriasis during haemodialysis. Br Med J (1978) 0.79
Activation of human complement by immunoglobulin G antigranulocyte antibody. J Clin Invest (1982) 0.79
Calcium ionophore A23187 induces release of chemokinetic and aggregating factors from polymorphonuclear leucocytes. Br J Pharmacol (1980) 0.79
Effect of drugs on the pulmonary changes in experimental acute pancreatitis in the rat. Gut (1982) 0.78
Reduction of circulating granulocytes induced by type 1 pneumococcal cell walls in New Zealand white rabbits. Infect Immun (1981) 0.78
Irreversible neutrophil aggregation. A mechanism of decreased newborn neutrophil chemotactic response. Am J Pathol (1981) 0.78
Comparison of inflammatory response following coronary revascularization with or without cardiopulmonary bypass. Exp Clin Cardiol (2004) 0.78
Polymorphonuclear leukocyte adherence to nylon: effect of oral corticosteroids. Infect Immun (1979) 0.78
Effects of Pasteurella haemolytica leukotoxic culture supernatant on bovine neutrophil aggregation. Can J Vet Res (1992) 0.77
Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure. Clin Exp Immunol (1989) 0.77
The role of C5a in acute lung injury induced by highly pathogenic viral infections. Emerg Microbes Infect (2015) 0.77
Changes in neutrophil surface phenotype during hemodialysis. Inflammation (1998) 0.77
Complement activated granulocytes can cause autologous tissue destruction in man. Mediators Inflamm (1992) 0.77
Thrombin-induced generation of neutrophil activating factors in blood. Am J Pathol (1988) 0.76
Clustering of neutrophil leucocytes in serum: possible role of C1q-containing immune complexes. Clin Exp Immunol (1993) 0.75
Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes. Clin Exp Immunol (1994) 0.75
Desensitization of calcium mobilization and cell function in human neutrophils. Biochem J (1989) 0.75
Stimulation of neutrophil functions by C5a(desArg): an in vitro model of haemodialysis. Mediators Inflamm (1992) 0.75
Differential inhibition of polymorphonuclear leukocyte recruitment in vivo by dextran sulphate and fucoidan. Mediators Inflamm (1996) 0.75
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med (1965) 15.47
Fine structural alterations induced in platelets by adenosine diphosphate. Blood (1968) 4.95
Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes. J Immunol (1973) 4.61
A neutrophil chemotactic factor from human C'5. J Immunol (1969) 4.46
Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest (1977) 4.08
Effects of the numbers and sizes of platelet aggregates on the optical density of plasma. Nature (1967) 2.67
Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways. Clin Immunol Immunopathol (1975) 2.56
Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. J Clin Invest (1975) 2.40
Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis. Immunochemistry (1972) 2.10
New biological activity following intravascular activation of the complement cascade. Nature (1974) 1.89
Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies. J Clin Invest (1976) 1.78
Influence of cytochalasin B on the shape change induced in platelets by cold. Blood (1973) 1.72
The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol (1983) 21.29
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26
The neural circuit for touch sensitivity in Caenorhabditis elegans. J Neurosci (1985) 7.13
Electron microscopical reconstruction of the anterior sensory anatomy of the nematode Caenorhabditis elegans.?2UU. J Comp Neurol (1975) 6.58
Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest (1978) 5.80
Fine structural alterations induced in platelets by adenosine diphosphate. Blood (1968) 4.95
Cortical flow in animal cells. Science (1988) 4.66
An evaluation of confocal versus conventional imaging of biological structures by fluorescence light microscopy. J Cell Biol (1987) 4.59
Multiphoton excitation provides optical sections from deeper within scattering specimens than confocal imaging. Biophys J (1998) 4.44
On the control of germ cell development in Caenorhabditis elegans. Dev Biol (1981) 4.28
Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22
Determination of cell division axes in the early embryogenesis of Caenorhabditis elegans. J Cell Biol (1987) 4.20
Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest (1977) 4.08
The structure of the ventral nerve cord of Caenorhabditis elegans. Philos Trans R Soc Lond B Biol Sci (1976) 3.94
Regulation and cell autonomy during postembryonic development of Caenorhabditis elegans. Dev Biol (1980) 3.88
Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest (1992) 3.50
Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet (2000) 3.50
Long-term two-photon fluorescence imaging of mammalian embryos without compromising viability. Nat Biotechnol (1999) 3.44
Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med (1977) 3.43
Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. Am J Pathol (1971) 3.04
The C. elegans zyg-1 gene encodes a regulator of centrosome duplication with distinct maternal and paternal roles in the embryo. Cell (2001) 2.92
Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci U S A (1993) 2.77
Completion of cytokinesis in C. elegans requires a brefeldin A-sensitive membrane accumulation at the cleavage furrow apex. Curr Biol (2001) 2.64
On the mechanisms of cytokinesis in animal cells. J Theor Biol (1983) 2.63
Cortical and cytoplasmic flow polarity in early embryonic cells of Caenorhabditis elegans. J Cell Biol (1993) 2.54
The dynactin complex is required for cleavage plane specification in early Caenorhabditis elegans embryos. Curr Biol (1998) 2.53
Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism. J Lab Clin Med (1984) 2.52
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood (1993) 2.48
Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet (1980) 2.47
Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. N Engl J Med (1980) 2.41
Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest (1980) 2.34
Interaction of membrane systems in blood platelets. Am J Pathol (1972) 2.32
Specific degranulation of human polymorphonuclear leukocytes. Nature (1974) 2.30
Selective labilization of specific granules in polymorphonuclear leukocytes by phorbol myristate acetate. Am J Pathol (1974) 2.27
An ultrastructural basis for the shape changes induced in platelets by chilling. Blood (1967) 2.20
The ultrastructural localization and release of platelet lipids. Blood (1966) 2.10
Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria. Am J Pathol (1985) 2.08
Dynamics and ultrastructure of developmental cell fusions in the Caenorhabditis elegans hypodermis. Curr Biol (1998) 2.04
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states. J Clin Invest (1979) 2.01
Activation of flavin-containing oxidases underlies light-induced production of H2O2 in mammalian cells. Proc Natl Acad Sci U S A (1999) 2.00
Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med (1983) 1.99
Mitogenic properties of a calcium ionophore, A23187. Proc Natl Acad Sci U S A (1974) 1.98
Elevated erythrocyte calcium in sickle cell disease. Nature (1973) 1.97
The Chediak-Higashi syndrome: a possible lysosomal disease. Blood (1966) 1.94
In vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions. Studies based on the acute neutropenia of filtration leukophoresis. J Exp Med (1977) 1.94
Effects of phorbol myristate acetate on the metabolism and ultrastructure of neutrophils in chronic granulomatous disease. J Clin Invest (1974) 1.92
The influence of phorbol myristate acetate on oxygen consumption by polymorphonuclear leukocytes. J Lab Clin Med (1974) 1.92
Replication occurs at discrete foci spaced throughout nuclei replicating in vitro. J Cell Sci (1989) 1.84
Plasma exchange in the treatment of immune disease. Transfusion (1976) 1.81
Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet (2001) 1.80
Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med (1974) 1.80
Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation. Blood (1980) 1.77
Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest (1991) 1.77
Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med (1991) 1.74
Influence of cytochalasin B on the shape change induced in platelets by cold. Blood (1973) 1.72
Platelet interaction with bacteria. II. Fate of the bacteria. Am J Pathol (1971) 1.71
Connectivity changes in a class of motoneurone during the development of a nematode. Nature (1978) 1.65
Uptake of latex particles by blood platelets: phagocytosis or sequestration? Am J Pathol (1972) 1.65
How the confocal laser scanning microscope entered biological research. Biol Cell (2003) 1.64
Effects of colchicine and vinca alkaloids on human platelets. 3. Influence on primary internal contraction and secondary aggregation. Am J Pathol (1969) 1.63
Effects of sulfhydryl inhibition on red blood cells. 3. Glutathione in the regulation of the hexose monophosphate pathway. J Biol Chem (1966) 1.62
Sudden blindness in acute pancreatitis. Possible role of complement-induced retinal leukoembolization. Arch Intern Med (1981) 1.62
Acute hemolytic anemia with rigid red cells in hypophosphatemia. N Engl J Med (1971) 1.60
Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion. Am J Pathol (1974) 1.59
Polyploid tissues in the nematode Caenorhabditis elegans. Dev Biol (1985) 1.59
Cell fusions in the developing epithelial of C. elegans. Dev Biol (1994) 1.58
Four-dimensional imaging: the exploration of space and time. Trends Biotechnol (1998) 1.57
Formation of the vulva in Caenorhabditis elegans: a paradigm for organogenesis. Development (1999) 1.57
Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol (1977) 1.56
Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome. Am J Hematol (1987) 1.56
A genetic screen for temperature-sensitive cell-division mutants of Caenorhabditis elegans. Genetics (1998) 1.55
Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest (1979) 1.54
Effects of colchicine and Vinca alkaloids on human platelets. I. Influence on platelet microtubules and contractile function. Am J Pathol (1968) 1.53
Complement activation and pulmonary leukotasis during nylon fiber filtration leukapheresis. Blood (1978) 1.52
The fine structure of sickled hemoglobin in situ. Blood (1968) 1.51
Cell cycling and DNA replication in a mutant blocked in cell division in the nematode Caenorhabditis elegans. Dev Biol (1978) 1.50
Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb (1991) 1.49
Chlorinated urban water: a cause of dialysis-induced hemolytic anemia. Science (1973) 1.49
Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med (1990) 1.48
The transfer of thorium particles from plasma to platelets and platelet granules. Am J Pathol (1968) 1.47
A search for the platelet secretory pathway using electron dense tracers. Am J Pathol (1970) 1.47
The C. elegans septin genes, unc-59 and unc-61, are required for normal postembryonic cytokineses and morphogenesis but have no essential function in embryogenesis. J Cell Sci (2000) 1.46
Ultrastructural studies of the gray platelet syndrome. Am J Pathol (1979) 1.45
Fibrinogen is the receptor for the endogenous lectin of human platelets. Nature (1981) 1.45
Abnormal haem binding and globin SH group blockade in unstable haemoglobins. Nature (1968) 1.44